[HTML][HTML] Matching Clostridioides difficile strains obtained from shoe soles of healthcare workers epidemiologically linked to patients and confirmed by whole-genome …

AC Büchler, M Wicki, R Frei, V Hinic… - Journal of Hospital …, 2022 - Elsevier
Background The source of transmission of Clostridioides difficile in healthcare institutions is
frequently unknown. The aim of this prospective cohort study was to assess the association …

Delivery of fecal material to terminal ileum is associated with long-term success of fecal Microbiota transplantation

AR Weingarden, O Treiger, L Ulsh, B Limketkai… - Digestive diseases and …, 2023 - Springer
Background Fecal microbiota transplantation (FMT) is a highly effective treatment for
recurrent Clostridioides difficile infection (CDI). However, 10–20% of patients still fail to …

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis

A Amin, WW Nelson, J Dreyfus… - Therapeutic …, 2022 - journals.sagepub.com
Objective: To describe mortality, healthcare resource utilization (HRU), and costs among
Medicare beneficiaries with primary Clostridioides difficile infection (pCDI) or recurrent CDI …

[HTML][HTML] Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients

H Ali, S Khurana, W Ma, Y Peng, ZD Jiang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Cancer patients are at increased risk of recurrent Clostridioides difficile
infection (rCDI) due to malignancy itself, cancer therapy, and frequent antibiotic use and …

[HTML][HTML] Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics

R Wang - Frontiers in Microbiology, 2023 - frontiersin.org
Clostridioides difficile is a gram-positive, spore-forming, obligate anaerobe that infects the
colon. C. difficile is estimated to cause nearly half a million cases in the United States …

Population-based incidence of hospitalized Clostridioides difficile infection among older adults in Ota-ku, Japan: a prospective surveillance study

K Tateda, J Ishida, S Ito, E Gonzalez, S Yoshizumi… - Anaerobe, 2022 - Elsevier
Objectives Clostridioides difficile infection (CDI) burden is not well-characterized in Japan.
Therefore, we conducted a population-based, hospitalized CDI incidence study, compared …

Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficile

K Fettucciari, P Marconi… - Therapeutic …, 2021 - journals.sagepub.com
Clostridioides difficile infection (CDI) is on the rise worldwide and is associated with an
increase in deaths and socio-health burden. C. difficile has become ubiquitous in …

Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2

D Yadav, S Khanna - Therapeutic Advances in …, 2021 - journals.sagepub.com
Clostridioides difficile infection (CDI) is a consequence of flagrant use of antibiotics, an
aging population with increasing comorbidities, and increased hospitalizations. The …

[HTML][HTML] A review of epidemiological models of Clostridioides difficile transmission and control (2009–2021)

C Lanzas, M Jara, R Tucker, S Curtis… - Anaerobe, 2022 - Elsevier
Clostridioides difficile is the leading cause of infectious diarrhea and one of the most
common healthcare-acquired infections worldwide. We performed a systematic search and …

[HTML][HTML] Vancomycin vs metronidazole use for the treatment of Clostridioides difficile infection in a tertiary care hospital in Saudi Arabia

AF Alhameed, N Saferuddin, T Alturkistani… - Heliyon, 2023 - cell.com
Abstract Background The 2017 Infectious Diseases Society of America (IDSA) Clostridioides
difficile infection (CDI) guidelines recommendation for oral vancomycin as preferred …